Detalles de la búsqueda
1.
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
BMC Cancer
; 23(1): 193, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849920
2.
The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis.
Therap Adv Gastroenterol
; 17: 17562848241237631, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38645513
3.
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1849-1859, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881221
4.
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Int Immunopharmacol
; 115: 109651, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638663
5.
Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Hepatol Int
; 16(4): 868-878, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35674872
6.
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy.
J Hepatocell Carcinoma
; 7: 337-345, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33294424
Resultados
1 -
6
de 6
1
Próxima >
>>